BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, January 18, 2025
Home
»
Newsletters
» BioWorld
BioWorld
July 26, 2002
View Archived Issues
Acusphere's 7th Round Brings $15M For Porous Microparticles
Read More
Innate Immunity Genetic Pathway Runs Caenorhabditis elegans To Homo sapiens, Tracking Evolution
Read More
Hydra Series A Round: $9.3M To Add To Team, Grow Science
Read More
Other News To Note
Read More
Correction
Read More
Anadys Raises $38.3M In Series C To Advance Hepatitis C Products
Anadys - it's research focus neatly split - raised $38.3 million in its Series C round in what could be its last financing before testing the investment waters with an initial public offering. (BioWorld Today)
Read More
